Active immunization by vaccination with tetanus toxoid is now usual in childhood, along with diphtheria and whooping cough vaccines. |
|
Tetanus toxoid is available in both vaccine fluid and alum-precipitated preparations. |
|
Quebec province had good results when it combined whooping cough vaccine with diphtheria toxoid. |
|
Following adequate immunization with diphtheria toxoid, it is generally accepted that protection persists for at least 10 years. |
|
Because it provides long-lasting protection and relative safety in humans, tetanus toxoid has proved to be an ideal vaccine. |
|
Serotypes 18C and 19F are conjugated to tetanus toxoid and to diphtheria toxoid, respectively. |
|
One third of infants do not receive routine immunization in the form of three doses of diphtheria, pertussis and tetanus toxoid vaccine. |
|
Grossly contaminated wounds containing devitalised tissue are at risk of infection with Clostridium tetani, and antitetanus serum and tetanus toxoid should be available. |
|
The bivalent toxoid, Td, is not considered to be significantly more reactogenic than T alone and is recommended for use in this circumstance. |
|
The currently used tetanus toxoid vaccine provides 100 percent protection but requires three to five injections over one to three years. |
|
It is important to ascertain the number of doses of toxoid previously given and the interval since the last dose. |
|
Give the mother tetanus toxoid, if required. |
|
Tetanus toxoid. 2006 Canadian Immunization Guide, 7th edn. |
|
The second meeting of the Group, held on 14 October 1992 in Geneva, agreed that a number of considerations have to be taken into account before microencapsulated tetanus toxoid vaccines could enter Phase I trials. |
|
On the basis of the table below, decide whether to administer tetanus toxoid, which gives active protection, and antitetanus immunoglobulin, if available, which gives passive protection. |
|
For persons 7 years and older, Td is preferred to tetanus toxoid alone. |
|
The efficacy of RAE was determined by using strong antigen tetanus toxoid and weak antigen Ovalbumin. |
|
Lymphocyte proliferation testing showed a normal response to phytohemagglutinin and concanavalin A, but minimal response to tetanus toxoid. |
|
It was not until the 1930s, however, that an efficient vaccine, or toxoid, as it is known in the cases of tetanus and diphtheria, was produced against tetanus. |
|
A more effective toxoid was introduced by the French bacteriologist Gaston Ramon in 1923, and with subsequent improvements this became one of the most effective vaccines available in medicine. |
|
|
These modified toxins, or toxoids, usually are adsorbed onto an inorganic gel before being administered, an approach that increases the likelihood that the toxoid will be retained in a macrophage. |
|
The introduction of diphtheria toxoid in the early 20th century led to a dramatic reduction in the incidence of the disease in many parts of the world. |
|
Supplementary tetanus toxoid vaccination campaigns were held in 30 countries, reaching more than 50 million women of reproductive age in the highest-risk districts. |
|
Tetanus toxoid is a highly effective antigen and a completed primary series generally induces serum antitoxin levels of at least 0.01 antitoxin units per mL, a level which has been reported to be protective. |
|
An estimated 94 per cent of infants receive routine immunization, as measured by coverage of infants receiving three doses of diphtheria, pertussis and tetanus toxoid vaccine. |
|
Routine immunization, measured by the percentage of infants receiving three doses of diphtheria, pertussis and tetanus toxoid vaccine, stood at 94 per cent. |
|